Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Archivos De Bronconeumologia|February 15, 2011
[New challenges in community-acquired pneumonia]Francisco Sanz Herrero, Nuria Marina Malanda, Beatriz Montull Veiga, et al.Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|January 31, 2014
Telemedicine spirometry training and quality assurance program in primary care centers of a public health systemNuria Marina Malanda, Elena López de Santa María, Asunción Gutiérrez, et al.COPD|March 21, 2018
Management of COPD in End-of-Life Care by Spanish PulmonologistsPatricia Sobradillo Ecenarro, Marta Inchausti Iguiñiz, Sandra Pedrero Tejada, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2019
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot StudyLuis A Pérez de Llano, Borja G Cosío, Christian Domingo, et al.Archivos De Bronconeumologia|June 26, 2017
Impact of Asthma on the Sexual Functioning of Patients. A Case-Control StudyJosé Gregorio Soto Campos, Josefa Rojas Villegas, Alicia Padilla Galo, et al.Journal of Asthma and Allergy|January 21, 2022
Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life DataLuis A Pérez de Llano, Borja G Cosío, Ignacio Lobato Astiárraga, et al.Journal of Asthma and Allergy|March 25, 2022
The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma-COPD Overlap SyndromeLuis Pérez de Llano, David Dacal Rivas, Nuria Marina Malanda, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 13, 2026
Geographical variability in severe asthma: comparison of patients' characteristics between national, regional and international cohorts in ISARMaria Kallieri, Nikolaos G Papadopoulos, Eleftherios Zervas, et al.Journal of Clinical Medicine|June 26, 2026
Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in SpainIsmael García-Moguel, Juan Agüero Calvo, Diana Betancor Pérez, et al.Respiratory Medicine|April 23, 2026
Temporal Trends in Baseline Severity and 12-Month Response to Mepolizumab in Severe Asthma: The TYREX Multicentre Real-World Study in Spain (2017-2024)Javier Domínguez-Ortega, Carlos Almonacid, Francisco Javier Alvarez-Gutiérrez, et al.Pageof 1